The global allergy medicine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Allergy medicine supports to block a certain natural substance such as histamine that the body makes during an allergic reaction. It works by drying allergic symptoms such as watery eyes and a runny nose by blocking another natural substance made by the body such as acetylcholine. The major factor for the growth of the market during the forecast period is the increasing prevalence of various types of allergies.

Moreover, the market is also growing due to the new product launches. For instance, in March 2018, Dr Reddy's Laboratories launched an ant- allergic drug, levocetirizine dihydrochloride, in tablet form in the US market. It is an over-the-counter therapeutic equivalent generic version of UCB's Xyzal allergy tablets for treating and relieving allergies. Additionally, in January 2020, Aimmune Therapeutics received approval for Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] from the US FDA. It is used for the treatment of peanut allergy in children.

Some major players in the market include Johnson & Johnson Services, Inc., Sanofi SA, and GlaxoSmithKline plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Cadila Pharmaceuticals Ltd. announced the launch of Bilastine syrup (30 ml) and Bilastine tablets in the strength of 20mg. It is an antihistamine drug used in the treatment of allergic rhinitis.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Distribution Channel

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- Johnson & Johnson Services, Inc., Sanofi SA, and GlaxoSmithKline plc, among others. 

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Allergy Medicine Market Report by Segment

By Type 

    • Eye Allergy

    • Rhinitis

    • Asthma

    • Skin Allergy

    • Food Allergy

    • Other 

By Distribution Channel 

    • Retail Pharmacy

    • Online Pharmacy

    • Others

Global Allergy Medicine Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa